{
	"kja6jc3xText": "Chr<span class=\"_ _2\"></span>isten<span class=\"_ _2\"></span>se<span class=\"_ _2\"></span>n MC et a<span class=\"_ _2\"></span>l. 2<span class=\"_ _c\"></span>0<span class=\"_ _2\"></span>2<span class=\"_ _2\"></span>0<span class=\"_ _c\"></span><span class=\"fs1 v1\">1</span>",
	"kja6jc3yText": "Patient<span class=\"_ _2\"></span>-level data fr<span class=\"_ _0\"></span>om 4 double<span class=\"_ _0\"></span>-blind, ran<span class=\"_ _0\"></span>domised, placebo<span class=\"_ _0\"></span>-cont<span class=\"_ _0\"></span>rolled shor<span class=\"_ _0\"></span>t-term <br><span class=\"ls17 ws25\">s<span class=\"_ _0\"></span>tudies and 1<span class=\"_ _0\"></span> long-term relapse prevention stu<span class=\"_ _0\"></span>dy<span class=\"_ _c\"></span>.</span>",
	"kja6jc3zText": "Study objective: <span class=\"ff3\">Investigate the ef<span class=\"_ _2\"></span>ficacy of Brintellix® (5-20 mg/day) vs. placebo in adults <br><span class=\"wsb\">with major depressive disor<span class=\"_ _2\"></span>der (MDD) who repor<span class=\"_ _2\"></span>t childhood or recent trauma assessed <br>at baseline,<span class=\"_ _c\"></span> according to an adapted version of the Childhood T<span class=\"_ _3\"></span>rauma Questionnair<span class=\"_ _2\"></span>e.</span></span>",
	"kja6jc40Text": "Back",
	"kja6jc41Text": "Meta-analysis of 4<span class=\"_ _0\"></span> <br>double-blind,  r<span class=\"_ _2\"></span>andomised, <br>fixed-dose,<span class=\"_ _2\"></span> placebo-<br>controlled short-term <br>efficacy studies (8 week<span class=\"_ _2\"></span>s):",
	"kja6jc42Text": "• Mahableshwarkar AR et al.<span class=\"_ _2\"></span>  <br>   2015b",
	"kja6jc43Text": "• Baldwin DS et al. 2012b",
	"kja6jc44Text": "• Jacobsen PL<span class=\"_ _2\"></span> et al. 2015c",
	"kja6jc45Text": "• Boulenger JP et al.<span class=\"_ _2\"></span> 2014",
	"kja6jc46Text": "5, 10,<span class=\"_ _c\"></span> 15 or 20 mg/day for <br>8 weeks",
	"kja6jc47Text": "The study pop<span class=\"_ _2\"></span>ulat<span class=\"_ _2\"></span>ion in a<span class=\"_ _2\"></span>ll 4 sh<span class=\"_ _2\"></span>or<span class=\"_ _0\"></span>t-<span class=\"_ _2\"></span>term studi<span class=\"_ _2\"></span>es and t<span class=\"_ _2\"></span>he rel<span class=\"_ _2\"></span>apse p<span class=\"_ _2\"></span>rev<span class=\"_ _2\"></span>enti<span class=\"_ _2\"></span>on study com<span class=\"_ _2\"></span>prise<span class=\"_ _2\"></span>d adults (<span class=\"_ _c\"></span>aged 1<span class=\"_ _3\"></span>8<span class=\"_ _0\"></span>-<span class=\"_ _c\"></span>75 y<span class=\"_ _c\"></span>ears<span class=\"_ _2\"></span>) with a <br>prim<span class=\"_ _2\"></span>ary diag<span class=\"_ _2\"></span>nosis o<span class=\"_ _2\"></span>f MDD ac<span class=\"_ _2\"></span>cord<span class=\"_ _2\"></span>ing t<span class=\"_ _2\"></span>o DS<span class=\"_ _2\"></span>M-IV-<span class=\"_ _c\"></span>TR criteri<span class=\"_ _c\"></span>a, curren<span class=\"_ _2\"></span>t majo<span class=\"_ _2\"></span>r depr<span class=\"_ _c\"></span>essive epis<span class=\"_ _2\"></span>ode of ≥<span class=\"_ _c\"></span>3 months’ d<span class=\"_ _2\"></span>urati<span class=\"_ _2\"></span>on (<span class=\"_ _c\"></span>confi<span class=\"_ _2\"></span>rmed <br><span class=\"ls4a ws83\">using the<span class=\"_ _0\"></span> Mini International N<span class=\"_ _0\"></span>europsychiatric<span class=\"_ _0\"></span> Inter<span class=\"_ _0\"></span>view)<span class=\"_ _2\"></span>, and a<span class=\"_ _0\"></span> Montgomer<span class=\"_ _0\"></span>y-<span class=\"_ _0\"></span>Åsb<span class=\"_ _0\"></span>erg Depression<span class=\"_ _0\"></span> Rating Sc<span class=\"_ _0\"></span>ale (MADRS) total s<span class=\"_ _0\"></span>core <br><span class=\"ls36 wsb\">≥2<span class=\"_ _2\"></span>6 at scree<span class=\"_ _2\"></span>nin<span class=\"_ _2\"></span>g and b<span class=\"_ _2\"></span>aseli<span class=\"_ _2\"></span>ne vis<span class=\"_ _2\"></span>its.</span></span>",
	"kja6jc48Text": "MADRS, Mont<span class=\"_ _2\"></span>gomery-Åsberg Depressio<span class=\"_ _2\"></span>n Rating Scal<span class=\"_ _2\"></span>e; HAM-A, Hamilto<span class=\"_ _2\"></span>n Anxiety Rating Scale<span class=\"_ _2\"></span>; CGI, C<span class=\"_ _2\"></span>linical G<span class=\"_ _2\"></span>lobal Imp<span class=\"_ _2\"></span>ression<span class=\"_ _c\"></span>; SDS, Sheehan D<span class=\"_ _2\"></span>isabil<span class=\"_ _2\"></span>it<span class=\"_ _0\"></span>y Scale<span class=\"_ _2\"></span>; <br><span class=\"ls65 wsb6\">SF-36, 36-<span class=\"_ _0\"></span>item shor<span class=\"_ _0\"></span>t-form<span class=\"_ _0\"></span> health sur<span class=\"_ _0\"></span>vey.</span>",
	"kja6jc49Text": "Outcome measures:",
	"kja6jc4aText": "All studies measured",
	"kja6jc4bText": "the efficacy for depressive",
	"kja6jc4cText": "symptoms and anxiety symptoms",
	"kja6jc4dText": "(MADRS &amp; HAM-A), over<span class=\"_ _2\"></span>all clinical",
	"kja6jc4eText": "impression of improvement (CGI),",
	"kja6jc4fText": "and overall functioning (SDS).",
	"kja6jc4gText": "The long-term relapse",
	"kja6jc4hText": "prevention study additionally",
	"kja6jc4iText": "measured health-r<span class=\"_ _2\"></span>elated",
	"kja6jc4jText": "quality of life (SF-36).",
	"kja6jc4kText": "1 double-blind, r<span class=\"_ _2\"></span>andomised, <br>placebo-controlled long-term <br>relapse prevention study:",
	"kja6jc4lText": "• Boulenger JP et al.<span class=\"_ _2\"></span> 2012",
	"kja6jc4mText": "5 and 10 mg/day for 24−64 weeks",
	"kja6jc4nText": "Eight-week double-blind treatment period",
	"Brintellix_91a4dea304": "<span class=\"ff2 fc0 fs13\">References</span>",
	"Brintellix_91dbf38702": "<div class=\"ff3 fc1\" style=\"font-size:15px;\"><span class=\"ff2\">1.</span> Christensen MC et al. J Affect Disord. 2020;263:258–266.</div>"
}
